www.oncnursingnews.com Open in urlscan Pro
76.76.21.123  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 cursor-pointer bg-search-box-button-bg text-search-box-button-text hover:bg-search-box-button-hover-bg hover:text-search-box-button-hover-text ronded rounded-md p-1 font-bold w-[20%]"></form>

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 bg-search-box-button-bg text-search-box-button-text ronded rounded-md p-1 font-bold w-[20%]"></form>

Text Content

News
Latest News
FDA News
Adverse Event Management
Supportive Care
Disparities in Cancer Care
Drug Safety
Radiation Oncology
Survivorship
Practice Management
Prevention
Contributors
Media
Podcasts
Videos
Conferences
Conference Coverage
Conference Listing
Publications
CME/CE
Continuing Education
Resources
Oncology Drug Crash Course
Webinars
Cancer Summary Slides
MPN Symptom Management
Subscribe
Print Subscription
eNewsletter
Partners



Specialty
Advanced Practice Providers
Clinical
Breast CancerGastrointestinal CancerGenitourinary CancerGynecologic
CancerHematologyImmunotherapyLung CancerMyeloproliferative NeoplasmsNurse
NavigationPreventionSupportive Care
Quality Improvement
News
Latest News
FDA News
Adverse Event Management
Supportive Care
Disparities in Cancer Care
Drug Safety
Radiation Oncology
Survivorship
Practice Management
Prevention
Contributors
Media
Podcasts
Videos
Conferences
Conference Coverage
Conference Listing
Publications
CME/CE
Continuing Education
Resources
Oncology Drug Crash Course
Webinars
Cancer Summary Slides
MPN Symptom Management
Subscribe
Print Subscription
eNewsletter
Partners

Choose a Specialty
 * Adverse Event Management
 * Brain Cancer
 * Breast Cancer
 * Disparities in Cancer Care
 * Drug Safety
 * Gastrointestinal Cancer
 * Genetics
 * Genitourinary Cancer
 * Gynecologic Cancers
 * Head and Neck Cancers
 * Hematology
 * Immuno-Oncology
 * Lung Cancer
 * Myeloproliferative Neoplasms
 * Nurse Navigation
 * Pediatric Cancer
 * Practice Management
 * Prevention
 * Radiation Oncology
 * Sarcomas
 * Skin Cancer
 * Supportive Care
 * Survivorship

Advertisement

Breast Cancer

| Lung Cancer

| Gynecologic Cancers

| Hematology

| Skin Cancer

| Supportive Care

| Adverse Event Management

| Brain Cancer

| Disparities in Cancer Care

| Drug Safety

| Gastrointestinal Cancer

| Genetics

| Genitourinary Cancer

| Head and Neck Cancers

| Immuno-Oncology

| Myeloproliferative Neoplasms

| Nurse Navigation

| Pediatric Cancer

| Practice Management

| Prevention

| Radiation Oncology

| Sarcomas

| Survivorship

View All >>
 * Adverse Event Management
 * Brain Cancer
 * Breast Cancer
 * Disparities in Cancer Care
 * Drug Safety
 * Gastrointestinal Cancer
 * Genetics
 * Genitourinary Cancer
 * Gynecologic Cancers
 * Head and Neck Cancers
 * Hematology
 * Immuno-Oncology
 * Lung Cancer
 * Myeloproliferative Neoplasms
 * Nurse Navigation
 * Pediatric Cancer
 * Practice Management
 * Prevention
 * Radiation Oncology
 * Sarcomas
 * Skin Cancer
 * Supportive Care
 * Survivorship


LATEST NEWS


Cadonilimab/Chemotherapy Meets Primary End Point in Phase 3 AK104-303 Trial
By Kristi Rosa
December 3rd 2023

Frontline cadonilimab (AK104) and platinum-based chemotherapy improved
progression-free survival in patients with recurrent or metastatic cervical
cancer.

First-Line Pembrolizumab Shows A Trend Towards Overall Survival in MSI-D/dMMR
mCRC
By Kristi Rosa
December 2nd 2023
FDA Grants Pirtobrutinib Accelerated Approval to Treat CLL/SLL in the Third Line
By Lindsay Fischer
December 2nd 2023
Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL
By Lindsay Fischer
December 1st 2023
Biosimilars Make Routine Prophylaxis With G-CSF Feasible in HER2+ Breast Cancer
By Lindsay Fischer
December 1st 2023
Watch Videos
Supporting the Patient's Psychosocial Needs Throughout MPN Treatment

MPN-Related Fatigue Has a ‘Profound Effect’ on Patients’ Quality of Life

Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic Tests

Elizabeth Aronson Walks Through the Data Supporting Elranatamab Approval in
Multiple Myeloma

Elizabeth Aronson Breaks Down Data From Behind Talquetamab Approval in Multiple
Myeloma

MPN-Associated Anemia: What Nurses Should Look Out For

Jennifer Cargile on Managing Cancer-Related Cognitive Impairment

Charina Toste Discusses the Educational Obstacles Patients With MPNs Face

Lindsey Lyle on Differentiating MPN Symptoms From Other Health Issues

Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse
Events

Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis

Yelena Shames on Pausing Immunotherapy for Laboratory Abnormalities

Johanna Garibaldi On Strengthening Cancer Prevention Tactics With Mobile
Screening Clinics

Elizabeth Cullen Discusses Avasopasem Manganese As A Potential Mucositis
Management Strategy in Head and Neck Cancers

Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in
HSCT Care

Seth Eisenberg Compares the Effectiveness of Plastic-Backed Pads Vs The
Splashblocker in Reducing Toilet Aerosols

Listen to The Vitals Podcast
Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

Racism Is Still Prevalent in Nursing

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Heather Santone Talks Barriers to Cancer Care in Older Populations

Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for
Patients With Head and Neck Cancer

Linda Bloom Shares Strategies To Improve Presurgical Communication With Patients
Who Have Limited English Proficiency

Leana Cabrera Chien and William Dale Underscore The Value of Geriatric
Assessments in Optimizing Cancer Care

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0
Trials

Recent Publications
Oncology Nurses Are Uniquely Qualified to Meet the Needs of Patients With Lung
Cancer

How I Counsel Patients About Lung Cancer Screening

Chasing the Target: MET Gene Abnormalities Open New Doors in NSCLC

The Uncommon Cancer: Thyroid Carcinoma

A Difficult Pill to Swallow

Colorectal Cancer Screening: Education, Advocacy, and Action

Developing a High-Risk Cancer Prevention and Wellness Program to Meet Community
Needs

CMS Predicts Health Care Spending Will Top $7 Trillion by 2031

Where Did All the Chemotherapy Go?

Improving Palliative Care Referrals Across Oncology

Latest CME Events & Activities

In-Person + Virtual EventCME

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!




In-Person + Virtual EventCME,CNE

PER's Breast Cancer Symposia in San Antonio

Register Now!




ActivityCME

Leukemia Therapy – A Look Into the Future

View More




In-Person + Virtual EventCME,CNE

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and
Exposition

Register Now!




Live Webcast RegistrationCME

Reflective Case-Based Oncology Collective: Real-World Applications of Novel
Therapies Across TNBC and Addressing Disparities in Care

View More




Burst CME™CME,CNE

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC
Care

View More




Burst CME™CME,CNE

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of
HER3 Expressing Cancers

View More




Burst CME™CME,CNE

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in
Breast Cancer Care

View More






ALL NEWS



Tenets of Counseling Cancer Survivors During Remission

By Lindsay Fischer
November 30th 2023


Experts with the University of Miami Sylvester Comprehensive Cancer Center share
their insights.



FDA Is Investigating Potential Secondary Cancer Risks Associated CAR T-Cell
Therapy

By Ashling Wahner
November 30th 2023


There have been reports of T-cell malignancies among patients who have undergone
CD19- or BCMA-directed autologous CAR T-cell immunotherapies.



Community Practices Share Their Experiences With the Oncology Care Model

By Lindsay Fischer
November 29th 2023


Leah Owens, DNP, OCN, RN, shares how the total cost of care changed over time at
her institution with the Oncology Care Model.



Why a Trauma-Informed Approach Is Ideal in Gynecologic Cancer Care

By Lindsay Fischer
November 29th 2023


Christina M. Wilson, PhD, CRNP, WHNP-BC, shares how providers can help their
patients feel empowered during their treatment.



Stress May Inhibit Immunotherapy’s Efficacy in Treating Cancer

By Lindsay Fischer
November 28th 2023


Finding ways to prevent and manage stress may be key to optimizing clinical
outcomes in oncology.



FDA OKs Nirogacestat for Adults Patients With Desmoid Tumors

By Kristi Rosa
November 28th 2023


The FDA has approved nirogacestat as a treatment for adults with progressing
desmoid tumors based off findings from the phase 3 DeFi trial.



PRO-TECT Trial Shows That ePROs May Be Feasibly Implemented Into Routine
Oncology Practice

By Lindsay Fischer
November 27th 2023


Electronic patient-reported outcomes may have a place in high-quality cancer
care, according to investigators.



Lenalidomide/Rituximab Induces Durable Responses in Mantle Cell Lymphoma in
9-Year Follow-Up

By Kyle Doherty
November 27th 2023


The combination of lenalidomide and rituximab led to a median progression-free
survival of 9 years—with 17 ongoing responses—among patients with mantle cell
lymphoma.



Pembrolizumab Plus Enzalutamide and ADT Falls Short in mHSPC

By Ryan Scott
November 26th 2023


Pembrolizumab, in addition to enzalutamide and androgen deprivation therapy, was
not associated with better radiographic progression-free survival outcomes in
patients with metastatic hormone-sensitive prostate cancer.



Olaparib Misses Mark in Recurrent Platinum-Sensitive Ovarian Cancer

By Courtney Flaherty
November 25th 2023


Olaparib did not significantly improve overall survival compared with
chemotherapy in recurrent, platinum-sensitive ovarian cancer.



Copanlisib Will No Longer Be Available in the US for Relapsed Follicular
Lymphoma

By Kristi Rosa
November 24th 2023


Manufacturers have announced that they will be withdrawing the new drug
application for copanlisib in adult patients with relapsed follicular lymphoma.



Investigators Highlight Benefits of Outpatient Delivery of Intensive
Chemotherapy

By Lindsay Fischer
November 24th 2023


Delivering intensive chemotherapy in the outpatient setting may preserve quality
of life and lead to significant cost savings, according to investigators.



Methylene Blue Has Potential to Transform Mucositis Management in Head and Neck
Cancer

By Amanda Brink, DNP, APRN, FNP-BC, AOCNP
November 23rd 2023


Nurses can be empowered to advocate for methylene blue therapy as an effective
oral mucositis pain relief treatment.



Patients With Prostate Cancer Report Better Quality of Life With 18 Months of
ADT vs 36 Months

By Lindsay Fischer
November 23rd 2023


Patients with prostate cancer who received 18 months of androgen deprivation
therapy were more likely to recover their serum testosterone levels and to
recover quicker than those who received 36 months of therapy.



LINE-1-ORF1p Is a Promising Biomarker for Early Cancer Detection, But More
Research Is Needed

By Amanda Brink, DNP, APRN, FNP-BC, AOCNP
November 22nd 2023


Oncology nurses can help patients understand the potential benefit of ORF1p
testing for early cancer detection and its current limitations.



Using ctDNA MRD Monitoring During Active Metastatic CRC Treatment

By Lindsay Fischer
November 22nd 2023


Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, shares her real-world experience
with circulating-tumor-DNA monitoring in the colorectal cancer setting.



Despite Treatment Advances, Oral Mucositis Continues to Plague Patients With
Head and Neck Cancer

By Lindsay Fischer
November 21st 2023


Data from a single-institution study showed that 98.6% of their patients with
head and neck cancer experienced oral mucositis.



Patients With Endometrial Cancer Report Maintained HRQOL With Dostarlimab

By Lindsay Fischer
November 21st 2023


Those receiving dostarlimab experienced numerical improvements from baseline in
terms of quality of life, emotional functioning, pain, and back and pelvis pain
scores.



New Management Strategies Seek to Improve Quality of Life for Patients With
Lymphedema

By Lindsay Fischer
November 20th 2023


Melanie Taylor, APRN, and Mark Lin, APRN, share how they optimize strategies in
caring for patients with lymphedema.



Most AYA Cancer Survivors Do Not Properly Understand Their Fertility Risks

By Lindsay Fischer
November 20th 2023


Proper counseling is needed to help decrease fertility-related psychological
distress in adolescent/young adult cancer survivors.



APPs Report High Levels of Prior Authorization-Related Burnout

By Lindsay Fischer
November 19th 2023


Advanced practice providers were more likely to be impacted by prior
authorizations than their physician colleagues, according to survey responses.



More Options Besides Steroids Are Needed to Manage irAEs in Cancer Care

By Jordyn Sava
November 18th 2023


Steroids are the standard approach in immune-related adverse events; however,
some experts maintain that other management strategies are needed.



Should You Wait for NGS Results Before Initiating NSCLC Treatment?

By Lindsay Fischer
November 17th 2023


Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance
of molecular testing in non–small cell lung cancer.



FDA Approves Enzalutamide for High-Risk Nonmetastatic Castration-Sensitive
Prostate Cancer

By Lindsay Fischer
November 17th 2023


The FDA has expanded the indication for enzalutamide to include patients with
high-risk nonmetastatic castration-sensitive prostate cancer.



‘More Isn’t Always Better’ With Adjuvant Chemotherapy in Colon Cancer

By Lindsay Fischer
November 17th 2023


Tammy Triglianos, DNP, ANP-BC, AOCNP, discusses optimal adjuvant treatment
approaches for patients with stage III colon cancer.


See All News >
Advertisement



LATEST CONFERENCE COVERAGE

Olanzapine Significantly Reduces CINV in Patients Receiving MEC



Reimagining Frailty Screenings in Head and Neck Cancer



Screening for Pain and Depression is Not Enough in Cancer Care



Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC

View More Latest Conference Coverage
Advertisement

Recent Content

Cadonilimab/Chemotherapy Meets Primary End Point in Phase 3 AK104-303 Trial



FDA Grants Pirtobrutinib Accelerated Approval to Treat CLL/SLL in the Third Line



Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL



Biosimilars Make Routine Prophylaxis With G-CSF Feasible in HER2+ Breast Cancer

View More Recent Content
Advertisement

x

CancerNetwork.com
CureToday.com
OncLive.com
TargetedOnc.com
Advertise
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777



© 2023 MJH Life Sciences

All rights reserved.